Geratherm Medical (GME) Financial Statements

10 Followers

Geratherm Medical Financial Overview

Geratherm Medical's market cap is currently €14.86M. The company's EPS TTM is €0.28; its P/E ratio is 16.41; and it has a dividend yield of 3.46%. Geratherm Medical is scheduled to report earnings on June 11, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Mar 22
Income Statement
Total Revenue	€ 14.86M	€ 20.43M	€ 20.96M	€ 25.85M	€ 24.64M
Gross Profit	€ 2.37M	€ 12.78M	€ 6.27M	€ 6.38M	€ 16.32M
Operating Income	€ -1.31M	€ 1.76M	€ 1.70M	€ 1.39M	€ 589.73K
EBITDA	€ -154.63K	€ 2.95M	€ 4.18M	€ 3.37M	€ 2.20M
Net Income	€ -818.99K	€ 705.17K	€ 1.11M	€ 1.02M	€ 122.23K
Balance Sheet
Cash & Short-Term Investments	€ 9.26M	€ 9.64M	€ 7.74M	€ 10.89M	€ 6.47M
Total Assets	€ 26.00M	€ 28.54M	€ 35.72M	€ 38.38M	€ 34.56M
Total Debt	€ 2.48M	€ 3.28M	€ 7.23M	€ 9.29M	€ 9.32M
Net Debt	€ -5.13M	€ -4.40M	€ 1.99M	€ 557.29K	€ 7.06M
Total Liabilities	€ 6.55M	€ 7.71M	€ 13.11M	€ 16.15M	€ 15.93M
Stockholders' Equity	€ 19.66M	€ 21.02M	€ 22.33M	€ 22.34M	€ 18.52M
Cash Flow
Free Cash Flow	€ 1.22M	€ 1.23M	€ -212.00K	€ -133.00K	€ -353.00K
Operating Cash Flow	€ 1.39M	€ 1.87M	€ 1.43M	€ 2.61M	€ 917.00K
Investing Cash Flow	€ -328.00K	€ 3.82M	€ -2.09M	€ -767.00K	€ 3.00K
Financing Cash Flow	€ -1.31M	€ -2.69M	€ -3.09M	€ 4.35M	€ -3.52M

Currency in EUR

Geratherm Medical Earnings and Revenue History

Income Statement >

Geratherm Medical Debt to Assets

Balance Sheet >

Geratherm Medical Cash Flow

Cash Flow >

Geratherm Medical Forecast EPS vs Actual EPS

Earnings >